Home › Trial NCT06717750
A Study of CSCJC3456 in Patients With Advanced Malignant Tumors
- Trial IDNCT06717750
- StatusRecruiting
- PhasePhase 1
- Study typeInterventional
- SponsorChangshan ConjuChem BioPharmaceutical Research and Development (Hebei) Co., Ltd.
- Enrollment102
- Start date2025-02-13
- ConditionsAdvanced Malignant Solid Tumors
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.